RAFFERTY ASSET MANAGEMENT, LLC – United Therapeutics Corporation Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$6.50M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +79.02% | 13.70K shares | 2.41M | $209.38 | 31.05K |
Q2 2022 | share | Decrease | -43.88% | -13.56K shares | -1.45M | $235.64 | 17.34K |
Q1 2022 | share | Increase | +10.53% | 2.94K shares | -496K | $179.41 | 30.91K |
Q4 2021 | share | Increase | +88.72% | 13.14K shares | 3.30M | $215.18 | 27.96K |
Q3 2021 | share | Increase | +1.74% | 253 shares | 122K | $184.58 | 14.81K |
Q2 2021 | share | Decrease | -30.23% | -6.31K shares | -879K | $179.41 | 14.56K |
Q1 2021 | share | Increase | +210.58% | 14.15K shares | 2.47M | $167.27 | 20.87K |
Q4 2020 | share | Decrease | -65.27% | -12.63K shares | -935K | $151.79 | 6.72K |
Q3 2020 | share | Increase | +134.01% | 11.08K shares | 954K | $101 | 19.35K |
Q2 2020 | share | Increase | +60.79% | 3.12K shares | 513K | $121 | 8.27K |
Q1 2020 | share | Decrease | -88.25% | -38.62K shares | -3.36M | $94.83 | 5.14K |
Q4 2019 | share | Decrease | -45.51% | -36.55K shares | -2.55M | $88.08 | 43.76K |
Q3 2019 | share | Increase | +27.10% | 17.12K shares | 1.47M | $79.75 | 80.32K |
Q2 2019 | share | Increase | +39.01% | 17.73K shares | -403K | $78.06 | 63.19K |
Q1 2019 | share | Increase | 0.00% | 45.46K shares | 5.33M | $117.37 | 45.46K |
Q1 2018 | share | Decrease | -100.00% | -27.45K shares | -4.06M | $112.36 | 0 |
Q4 2017 | share | Increase | 0.00% | 27.45K shares | 4.06M | $147.95 | 27.45K |
Q4 2016 | share | Decrease | -100.00% | -5.17K shares | -611K | $143.43 | 0 |
Q3 2016 | share | Decrease | -69.64% | -11.86K shares | -1.19M | $118.08 | 5.17K |
Q2 2016 | share | Increase | 0.00% | 17.04K shares | 1.80M | $105.92 | 17.04K |